Skip to content

Treatment of Popliteal Aneurysms With VIABAHN Stent Graft in Elective Surgery

Treatment of Popliteal Aneurysms With VIABAHN Stent Graft in Elective Surgery: Multicenter Prospective Registry of the Research in Vascular Surgery University Association (AURC)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03996889
Acronym
VAP-AURC
Enrollment
50
Registered
2019-06-25
Start date
2019-09-30
Completion date
2022-09-30
Last updated
2019-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Popliteal Aneurysm

Brief summary

This multicentric, prospective study will evaluate the medium-term outcomes of patients implanted with GORE VIABAHN® stent grafts for popliteal artery aneurysms in scheduled elective surgery with the registry of the Research in Vascular Surgery University Association (AURC)

Interventions

DEVICEEndovascular treatment of aneurysms of the popliteal artery by GORE VIABAHN® stent in elective surgery

The intervention can be performed under local anesthesia (LA), regional locus (ALR) or general anesthesia (AG) (data collected) by first approach: percutaneous or conventional. The data collected are: * Number of GORE VIABAHN® stent used (length and diameter of each) * Embolization of collaterals and other related actions * Operative complications * Intraoperative fibrinolysis * Collar cover\> 2 cm * Lack of overlap in the overlap zone (nb: between 4 and 8 cm above the joint spacing) * Arteriography in profile, kink

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 18 years old at time of treatment * symptomatic or asymptomatic popliteal artery aneurysm needing surgery * scheduled elective surgery

Exclusion criteria

* life expectancy of \<1 year * thrombotic occlusion of popliteal artery * intolerance to antiplatelet drugs (antiaggregants) * known allergies to GORE VIABAHN® stent graft materials/composition * emergency surgery

Design outcomes

Primary

MeasureTime frameDescription
Major limb events2 years of follow-upComposite criterion associating Target Lesion Revascularization (TLR) and Rate of major amputation. An Echo-Doppler imaging examination will be performed and the following parameters and information should be collected: * Permeability * Intra-stent restenosis * Systolic pressure index

Countries

France

Contacts

Primary ContactNellie DELLA SCHIAVA, MD
dellaschiava.nellie@neuf.fr4 72 11 76 76

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026